[시장보고서]HTS(High Throughput Screening) 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

HTS(High Throughput Screening) 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

High Throughput Screening Market Size, Share & Trends Analysis Report By Product And Services (Consumables), By Technology (Cell-based Assays), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

상품코드 : 1553462

리서치사 : Grand View Research

발행일 : 2024년 08월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

HTS(High Throughput Screening) 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, HTS(High Throughput Screening) 세계 시장 규모는 2024년부터 2030년까지 10.6%의 CAGR을 기록하며 2030년까지 416억 7,000만 달러에 달할 것으로 예상됩니다.

제약회사들이 새로운 분자를 시장에 도입하기 위해 빠르고 정확한 기술을 채택하는 사례가 증가함에 따라 시장이 크게 성장할 것으로 예상됩니다.

HTS(High Throughput Screening)은 화학적, 약리학적, 유전학적 반응 등 다양한 근거를 바탕으로 개발 단계의 분자를 테스트하는 데 사용됩니다. 이러한 스크리닝은 실시간 결과와 분자와 신체 사이의 자연 반응을 모방한 자연에 가까운 조건을 기반으로 약물을 설계하고 개발하는 데 도움이 됩니다.

또한, 이 방법은 짧은 시간에 상당한 양의 데이터를 저장하고 처리하는 데이터 저장 장치와 함께 완전 자동화된 프로세스를 처리할 수 있는 필요한 하드웨어와 소프트웨어를 사용하여 완전히 자동화할 수 있습니다.

2016년 현재, HTS(High Throughput Screening) 시험의 약 55.0%가 세포 기반 분석에 기반하여 수행되고 있습니다. 세포 기반 분석은 주로 경로 및 메커니즘과 함께 세포 수준에서 얻을 수 있는 결과 때문에 주로 사용되고 있습니다.

이러한 분석은 세포사멸을 포함한 세포 독성 테스트에서 세포 대사 분석에 이르기까지 다양합니다. 또 다른 주요 기술 도입은 3D 세포배양의 도입으로, 이는 자연 조건을 모방하는 데 도움이되며 수행 된 테스트에 더 정확한 결과와 반응을 제공합니다. 이러한 추세는 예측 기간 동안 시장 성장을 지원할 것으로 예상됩니다.

HTS(High Throughput Screening) 시장 보고서 하이라이트

시장은 새로운 분자를 도입하기 위한 제약사들 간의 경쟁이 치열해짐에 따라 주도되고 있습니다.
실시간으로 더 나은 결과를 제공하는 3D 세포배양 기술의 등장으로 시장이 활성화되고 있습니다.
북미는 이 기술 개발 및 도입의 뚜렷한 핫스팟으로 부상하여 시장에서 큰 점유율을 차지하고 있습니다.
아시아태평양 및 라틴아메리카 등 신흥 지역은 다양한 질병을 치료하기 위한 새로운 분자의 필요성으로 인해 예측 기간 동안 수요가 크게 증가할 것으로 예상됩니다.

HTS(High Throughput Screening) 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
- 쿠웨이트

제9장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc
- Aurora Biomed Inc.
- Tecan Trading AG
- Promega Corporation
- Charles River Laboratories.
- Creative Biolabs.

ksm

영문 목차

영문목차

High Throughput Screening Market Growth & Trends:

The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

High Throughput Screening Market Report Highlights:

The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
Emerging 3D cell culture technology that provides better results in real-time is set to boost the market
North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. High Throughput Screening (HTS) Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. High Throughput Screening (HTS) Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. High Throughput Screening (HTS) Market: Product and Services Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. High Throughput Screening (HTS) Market: Product and services Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Consumables
- 4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.3.1.1. Reagents & Assay Kits
    - 4.3.1.1.1. Reagents & Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.3.1.2. Laboratory Equipment
    - 4.3.1.2.1. Laboratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Instruments
- 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.1. Liquid Handling Systems
    - 4.4.1.1.1. Liquid Handling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.2. Detection Systems
    - 4.4.1.2.1. Detection Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.3. Other Instruments
    - 4.4.1.3.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Software
- 4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. High Throughput Screening (HTS) Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. High Throughput Screening (HTS) Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Cell-based Assays
- 5.3.1. Cell-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.1. Fluorometric Imaging Plate Reader Assays
    - 5.3.1.1.1. Fluorometric Imaging Plate Reader Assays Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.1.2. Clinical Applications
      - 5.3.1.1.2.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.1.3. In-vitro Studies
      - 5.3.1.1.3.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.2. Reporter Based Assays
    - 5.3.1.2.1. Clinical Applications
      - 5.3.1.2.1.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.2.2. In-vitro Studies
      - 5.3.1.2.2.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.3. 3D - Cell Cultures
    - 5.3.1.3.1. 3D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.3.2. Scaffold-based Technology
      - 5.3.1.3.2.1. Scaffold-based Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.3.3. Scaffold-free Technology
      - 5.3.1.3.3.1. Scaffold-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.4. 2D - Cell Cultures
    - 5.3.1.4.1. 2D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.5. Reporter-based Assays
    - 5.3.1.5.1. Reporter-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.6. Perfusion Cell Culture
    - 5.3.1.6.1. Perfusion Cell Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Lab-on-a-chip Technology (LOC)
- 5.4.1. Lab-on-a-chip Technology (LOC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Label-free Technology
- 5.5.1. Label-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Ultra High Throughput Screening
- 5.6.1. Ultra High Throughput Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. High Throughput Screening (HTS) Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. High Throughput Screening (HTS) Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Drug Discovery Programs
- 6.3.1. Drug Discovery Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Chemical Biology Programs
- 6.4.1. Chemical Biology Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Biochemical Screening
- 6.5.1. Biochemical Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Cell & Organ-based Screening
- 6.6.1. Cell & Organ-based Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. High Throughput Screening (HTS) Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. High Throughput Screening (HTS) Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Pharmaceutical & Biopharmaceutical Companies
- 7.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Research Institutes
- 7.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Contract Research Organizations (CROs)
- 7.5.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Others
- 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. High Throughput Screening (HTS) Market: Regional Estimates & Trend Analysis

8.1. High Throughput Screening (HTS) Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
- 8.2.1. North America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.3. Canada
  - 8.2.3.1. Canada High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
- 8.3.1. Europe High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.2. U.K.
  - 8.3.2.1. U.K. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.3. Germany
  - 8.3.3.1. Germany High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.4. France
  - 8.3.4.1. France High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.5. Italy
  - 8.3.5.1. Italy High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.6. Spain
  - 8.3.6.1. Spain High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.9. Norway
  - 8.3.9.1. Norway High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
- 8.4.1. Asia Pacific High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.2. China
  - 8.4.2.1. China High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.3. Japan
  - 8.4.3.1. Japan High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.4. India
  - 8.4.4.1. India High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.5. South Korea
  - 8.4.5.1. South Korea High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.6. Australia
  - 8.4.6.1. Australia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
- 8.5.1. Latin America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.2. Saudi Arabia
  - 8.6.2.1. Saudi Arabia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.3. UAE
  - 8.6.3.1. UAE High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.4. South Africa
  - 8.6.4.1. South Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Agilent Technologies, Inc.
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Danaher Corporation
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Thermo Fisher Scientific Inc.
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. PerkinElmer Inc.
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Bio-Rad Laboratories, Inc
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Aurora Biomed Inc.
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Tecan Trading AG
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Promega Corporation
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Charles River Laboratories.
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Creative Biolabs.
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives

한글목차

HTS(High Throughput Screening) 시장 성장 및 동향:

HTS(High Throughput Screening) 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 HTS(High Throughput Screening) 시장 변수, 동향, 범위

제4장 HTS(High Throughput Screening) 시장 : 제품 및 서비스별 추정·동향 분석

제5장 HTS(High Throughput Screening) 시장 : 기술별 추정·동향 분석

제6장 HTS(High Throughput Screening) 시장 : 용도별 추정·동향 분석

제7장 HTS(High Throughput Screening) 시장 : 최종 용도별 추정·동향 분석

제8장 HTS(High Throughput Screening) 시장 : 지역별 추정·동향 분석